.Value Access Policy Manager – Barcelona – Spain barcelona Value Access Policy Manager – Barcelona – Spain Barcelona Barcelona, Catalonia, ES Reporting to the National Head of Value Access Policy this role represents a unique opportunity to own a sizable part of the Value Access and Policy function and national level. Candidates for this role will already have robust and demonstrable expertise in Pharmacoeconomics, as well as an in depth knowledge of the different regional health authorities, key contacts and policy makers.As a Value Access Policy manager you will be given freedom and true ownership of relevant relationships across our global organization, as well as local authorities and stakeholders. To succeed in this role you will take truly hands-on approach and self- empower to perform gap analysis when required, and formulate creative solutions accordingly to contribute to the sustainability of the health system. You previous experience must include extensive exposure to high specialty care products, including rare disease medicines.Main responsibilities:Health policy:Knowledge of the national health environment, health plans, lines of work in investment of the key interlocutors in the administrationTogether with the Access Director, establish a collaborative and trusting relationship with key interlocutors in the Public Administration (Health System, both the ministry, technology assessment entities, payers and providers)Size and anticipate the impact of the new regulations of our health system, so that possible negative impacts for the company are minimizedPatient Access and HEOR:Establish the access needs by brand to define the priorities of future pipelineCoordinate the strategy and process of price and reimbursement negotiation with the Ministry during the financing and pricing procedure of new drugsCoordinate the execution of the national strategy and tactics to guarantee access to our products at the national level (value dossier, economic models.. )Develop value at the HEOR level.Apply both internal and external pricing policies that comply with current regulations.Key measures of successOffer the company a comprehensive vision of the national health system, identifying the different stakeholders and their needs.Proposal, development and achievement of access plans for optimal access to the drugProposal, development and achievement of value projects throughout the life cycle of the products incorporating the priorities of the company and external to ensure that the value proposition is accepted and maximized in the market
